Roche CEO Severin Schwan to stand down after 14 years
pharmaphorum
JULY 21, 2022
The appointment might raise some eyebrows given Roche’s need to drive pharma sales as it copes with the loss of patent protection on an earlier generation of antibody-based therapies – now being hit by biosimilar competition – but Schwan is confident Schinecker is the right man to lead the company forward.
Let's personalize your content